Sarcoidosis vasculitis and diffuse lung diseases

Published: 2011-06-01

Review

Original Articles: Laboratory Research

The investigation of HLA microsatellites influence in predisposition to sarcoidosis among Croatians

Z. Grubić, T. Peroš-Golubičić, K. Štingl, et al.
Abstract 13 | PDF (Italiano) Downloads 2

Page 18-26

Surfactant protein D and KL-6 serum levels in systemic sclerosis: correlation with lung and systemic involvement

F. Bonella, A. Volpe, P. Caramaschi, et al.
Abstract 43 | PDF (Italiano) Downloads 10

Page 27-33

Original Articles: Clinical Research

Factor analysis of sarcoidosis phenotypes at two referral centers in Brazil

S.C.S. Rodrigues, N.A.S. Rocha, M.S. Lima, et al.
Abstract 35 | PDF (Italiano) Downloads 4

Page 34-43

Non-caseating granulomas in patients after the diagnosis of cancer: clinical characteristics and outcome

S. Butt, R. Alzebdeh, T.D. Kable, et al.
Abstract 51 | PDF (Italiano) Downloads 5

Page 44-49

Metabolism-perfusion imaging to predict disease activity in cardiac sarcoidosis

M. Isiguzo, R. Brunken, P. Tchou, et al.
Abstract 32 | PDF (Italiano) Downloads 2

Page 50-55

Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force

R.P. Baughman, S. Nagai, M. Balter, et al.
Abstract 106 | PDF (Italiano) Downloads 27

Page 56-64

Type D or “distressed” personality in sarcoidosis and idiopathic pulmonary fibrosis

M.D.P. Elfferich, J. De Vries, M. Drent
Abstract 65 | PDF (Italiano) Downloads 5

Page 65-71

Case reports

An isolated hand tumour as primary manifestation of sarcoidosis

S. Altmann, J. Schreiber, H-G. Damert, et al.
Abstract 24 | PDF (Italiano) Downloads 1

Page 72-74

Rapid improvement of osseous sarcoidosis after the treatment of pulmonary aspergillosis by itraconazole

K. Murakami, T. Tamada, K. Abe, et al.
Abstract 37 | PDF (Italiano) Downloads 6

Page 75-78

Letter to editor

Another “chance” for Interferon gamma 1b?

G.L. Casoni, M. Chilosi, M. Romagnoli, et al.
Abstract 8 | PDF (Italiano) Downloads 9

Page 79-80